UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Immunology of Epstein-Barr Virus-Induced Disease

Annual review of immunology, 2015-03, Vol.33 (1), p.787-821

2015

Volltextzugriff (PDF)

The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog

Frontiers in immunology, 2019-09, Vol.10, p.2193

2019

Volltextzugriff (PDF)

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

PLoS pathogens, 2021-12, Vol.17 (12), p.e1010137-e1010137

2021

Volltextzugriff (PDF)

Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.112827-112827, Article 112827

2023

Volltextzugriff (PDF)

Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner

Cell reports (Cambridge), 2023-03, Vol.42 (3), p.112207-112207, Article 112207

2023

Volltextzugriff (PDF)

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

PLoS pathogens, 2009-03, Vol.5 (3), p.e1000341-e1000341

2009

Volltextzugriff (PDF)

Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised children

BMJ open, 2023-10, Vol.13 (10), p.e079582-e079582

2023

Volltextzugriff (PDF)

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

PLoS pathogens, 2016-04, Vol.12 (4), p.e1005549-e1005549

2016

Volltextzugriff (PDF)

Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children

PLoS pathogens, 2015-03, Vol.11 (3), p.e1004746-e1004746

2015

Volltextzugriff (PDF)

Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2

PLoS pathogens, 2011-12, Vol.7 (12), p.e1002455-e1002455

2011

Volltextzugriff (PDF)

Targeting EBV-positive B- and T/NK-cell lymphomas

Blood, 2018-11, Vol.132 (22), p.2315-2316

Long, Heather M.

2018

Volltextzugriff (PDF)

EXTOD-Immune: a randomised controlled trial to investigate whether a remotely monitored, home-based exercise intervention can reduce disease activity in people with type 1 diabetes

BMJ Open Sport & Exercise Medicine, 2024, Vol.10 (3), p.e002144

2024

Volltextzugriff (PDF)

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Nature immunology, 2021-05, Vol.22 (5), p.620-626

2021

Volltextzugriff (PDF)

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease

Frontiers in immunology, 2019-10, Vol.10, p.2489-2489

2019

Volltextzugriff (PDF)

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

Journal for immunotherapy of cancer, 2018-07, Vol.6 (1), p.70-70, Article 70

2018

Volltextzugriff (PDF)

Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200

Journal of Virology, 2012-06, Vol.86 (11), p.6246-6257

2012

Volltextzugriff (PDF)

Bioengineered small extracellular vesicles deliver multiple SARS‐CoV‐2 antigenic fragments and drive a broad immunological response

Journal of extracellular vesicles, 2024-02, Vol.13 (2), p.e12412-n/a

2024

Volltextzugriff (PDF)

Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory

Trends in immunology, 2014-04, Vol.35 (4), p.159-169

2014

Volltextzugriff (PDF)

Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4 + T cell recognition

Nature immunology, 2022-12, Vol.23 (12), p.1726-1734

2022

Volltextzugriff (PDF)

Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases

Journal of virology, 2017-11, Vol.91 (21)

2017

Volltextzugriff (PDF)

Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4 + T Cells

The Journal of immunology (1950), 2019-09, Vol.203 (5), p.1276-1287

2019

Volltextzugriff (PDF)

T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display

PLoS pathogens, 2009-12, Vol.5 (12), p.e1000699-e1000699

2009

Volltextzugriff (PDF)

Immune defence against EBV and EBV-associated disease

Current opinion in immunology, 2011-04, Vol.23 (2), p.258-264

2011

Volltextzugriff (PDF)

MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response

The Journal of experimental medicine, 2013-05, Vol.210 (5), p.933-949

2013

Volltextzugriff (PDF)

1 – 25 von 302

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(247)

Publikationsform

Sprache

Englisch
(301)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Immunology of Epstein-Barr Virus-Induced Disease

The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity

Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

Immunology of THymectomy And childhood CArdiac transplant (ITHACA): protocol for a UK-wide prospective observational cohort study to identify immunological risk factors of post-transplant lymphoproliferative disease (PTLD) in thymectomised children

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination

Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children

Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2

Targeting EBV-positive B- and T/NK-cell lymphomas

EXTOD-Immune: a randomised controlled trial to investigate whether a remotely monitored, home-based exercise intervention can reduce disease activity in people with type 1 diabetes

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200

Bioengineered small extracellular vesicles deliver multiple SARS‐CoV‐2 antigenic fragments and drive a broad immunological response

CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles

Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory

Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4 + T cell recognition

Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases

Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4 + T Cells

T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display

Immune defence against EBV and EBV-associated disease

MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response

Suchergebnisse filtern